4 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
19 May 23
Regulation FD Disclosure
9:15am
American 1 (2%) 0 (0%) 1 (2%) Asian 2 (5%) 1 (11%) 3 (6%) Ethnicity, n (%) Non-Hispanic 40 (98%) 8 (89%) 48 (96%) Hispanic or Latino 0 (0%) 1 (11%) 1 (2
8-K
EX-99.1
CADL
Candel Therapeutics Inc
6 Dec 22
Regulation FD Disclosure
8:01am
(6) Squamous 15 (29) Ethnicity n (%) ICI at study entry n (%) Not Hispanic or Latino 48 (92) Durvalumab 2 (4) Not Reported 4 (8) Nivolumab 5 (10) PD-L1 … (95) Asian 1(2) Mutant 2(5) Not reported 2(5) Histopathologic diagnosis Ethnicity Glioblastoma 40(98) Not Hispanic or Latino 38(93) Diffuse astrocytoma
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic Background
In addition
- Prev
- 1
- Next